A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy

Author:

Chang Mengyu12,Wang Man34ORCID,Liu Bin3,Zhong Wenbin1,Jana Deblin1,Wang Yifan2,Dong Shiyan2,Antony Abin2,Li Chunxia4ORCID,Liu Yuhui5,Zhao Zhongqi6,Lin Jun3ORCID,Jiang Wen2ORCID,Zhao Yanli1ORCID

Affiliation:

1. School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, 637371, Singapore

2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States

3. State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China

4. Institute of Molecular Sciences and Engineering, Shandong University, Qingdao 266237, P. R. China

5. State Key Laboratory of Nuclear Resources and Environment, East China University of Technology, Nanchang 330013, P. R. China

6. Department of Electrical and Computer Engineering, University of Houston, Houston, Texas 77004, United States

Funder

National Research Foundation Singapore

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3